<?xml version="1.0" encoding="UTF-8"?>
<results title="disease">
 <result pre="SAS. pmcid: 7217786S1286-4579(20)30083-6 doi: 10.1016/j.micinf.2020.05.005 : Article Comparative review of" exact="respiratory" post="diseases caused by coronaviruses and influenza A viruses during"/>
 <result pre="during epidemic season JiangChaoab1YaoXingangc1ZhaoYulina1WuJianminaHuangPanaPanChunhuachungenp@163.comdâˆ—LiuShuwenliusw@smu.edu.cncâˆ—âˆ—PanChungenchhpan@163.comaâˆ—âˆ—âˆ—[a], [b], [c], [d], âˆ—Corresponding author. Affiliated" exact="Cancer" post="Hospital and Institute of Guangzhou Medical University, No. 78,"/>
 <result pre="- including this research content - immediately available in PubMed" exact="Central" post="and other publicly funded repositories, such as the WHO"/>
 <result pre="as long as the COVID-19 resource centre remains active. Abstract" exact="Severe" post="acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to sweep"/>
 <result pre="long as the COVID-19 resource centre remains active. Abstract Severe" exact="acute" post="respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to sweep the"/>
 <result pre="as the COVID-19 resource centre remains active. Abstract Severe acute" exact="respiratory" post="syndrome coronavirus 2 (SARS-CoV-2) continues to sweep the world,"/>
 <result pre="the COVID-19 resource centre remains active. Abstract Severe acute respiratory" exact="syndrome" post="coronavirus 2 (SARS-CoV-2) continues to sweep the world, causing"/>
 <result pre="syndrome coronavirus 2 (SARS-CoV-2) continues to sweep the world, causing" exact="infection" post="of millions and death of hundreds of thousands. The"/>
 <result pre="infection of millions and death of hundreds of thousands. The" exact="respiratory" post="disease that it caused, COVID-19 (stands for coronavirus disease"/>
 <result pre="of millions and death of hundreds of thousands. The respiratory" exact="disease" post="that it caused, COVID-19 (stands for coronavirus disease in"/>
 <result pre="The respiratory disease that it caused, COVID-19 (stands for coronavirus" exact="disease" post="in 2019), has similar clinical symptoms with other two"/>
 <result pre="has similar clinical symptoms with other two CoV diseases, severe" exact="acute" post="respiratory syndrome and Middle East respiratory syndrome (SARS and"/>
 <result pre="similar clinical symptoms with other two CoV diseases, severe acute" exact="respiratory" post="syndrome and Middle East respiratory syndrome (SARS and MERS),"/>
 <result pre="clinical symptoms with other two CoV diseases, severe acute respiratory" exact="syndrome" post="and Middle East respiratory syndrome (SARS and MERS), of"/>
 <result pre="two CoV diseases, severe acute respiratory syndrome and Middle East" exact="respiratory" post="syndrome (SARS and MERS), of which causative viruses are"/>
 <result pre="CoV diseases, severe acute respiratory syndrome and Middle East respiratory" exact="syndrome" post="(SARS and MERS), of which causative viruses are SARS-CoV"/>
 <result pre="CoVs resulting diseases also share many clinical symptoms with other" exact="respiratory" post="diseases caused by influenza A viruses (IAVs). Since both"/>
 <result pre="seasons, clinicians and public heath may have to distinguish COVID-19" exact="pneumonia" post="from other kinds of viral pneumonia. This is a"/>
 <result pre="may have to distinguish COVID-19 pneumonia from other kinds of" exact="viral pneumonia." post="This is a discussion and comparison of the virus"/>
 <result pre="Prevention In December 2019, a novel coronavirus, SARS-CoV-2, caused a" exact="pneumonia" post="epidemic in Wuhan, Hubei province of China. It erupted"/>
 <result pre="the following months and eventually became a worldwide pandemic. The" exact="pneumonia" post="was officially named COVID-19 by World Health Organization (WHO)"/>
 <result pre="circumstances, circulating together with the SARS-CoV-2 and causing more serious" exact="respiratory" post="diseases [4,5]. It is necessary to investigate whether the"/>
 <result pre="to investigate whether the simultaneous prevalence of SARS-CoV-2 and other" exact="respiratory" post="viruses, such as IAVs, can promote the spreading of"/>
 <result pre="addition, because the clinical symptoms caused by CoVs and IAVs" exact="infection" post="are very similar to each other [6], it will"/>
 <result pre="membrane fusing with cell membrane or endosome membrane and releasing" exact="viral" post="RNA, then the virus positive-sense RNA was used as"/>
 <result pre="to transcript mRNAs and also to replicate progeny positive-sense RNA." exact="Viral" post="proteins were translated by mRNAs through the endoplasmic reticulum"/>
 <result pre="endoplasmic reticulum and Golgi apparatus system for packaging into mature" exact="viral" post="particles with the progeny RNA in the cytoplasm. Then"/>
 <result pre="pathogenic avian viruses, H5N1 and H7N9 viruses, had caused severe" exact="respiratory" post="diseases and resulted in thousands of deaths or high"/>
 <result pre="H3N2) to form endosome and enters into cell, and the" exact="viral" post="RNA was released into the cytoplasm by viral-endosome membrane"/>
 <result pre="released into the cytoplasm by viral-endosome membrane fusion. Then the" exact="viral" post="RNA is imported into the nucleus, and once there"/>
 <result pre="CoVs and IAVs were identified as the major pathogens for" exact="respiratory" post="diseases in last century, they have traveled to many"/>
 <result pre="senior 1568 by December of 2019 Mainly in china 37%" exact="Avian" post="[42,47][48] H1N1pdm09 2009 Yes Yes Yes Most were younger"/>
 <result pre="Yes Yes Most were younger 861 (2003â€&quot;2020) 17 (2003â€&quot;2020) 53%" exact="Avian" post="[41,49][51] Seasonal HCoVsa 1966 Yes Yes Yes All ages"/>
 <result pre="deaths in younger people [38]. H7N9 and H5N1 viruses were" exact="limited" post="in transmission due to the similar reason mentioned above"/>
 <result pre="these viruses are of animal origin or use animals as" exact="intermediate" post="hosts [29,31], it is necessary to keep a safe"/>
 <result pre="little longer than other viruses. At the early stage of" exact="disease" post="onset, the cases with the infection of different viruses"/>
 <result pre="the early stage of disease onset, the cases with the" exact="infection" post="of different viruses mostly developed the same clinical symptoms"/>
 <result pre="in HPHTs infection, but not common in seasonal virus infections." exact="Diarrhea" post="was usually observed in patients with MERS and SARS,"/>
 <result pre="ï¼‹ Cough ï¼‹d ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹" exact="Fever" post="ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ Myalgia"/>
 <result pre="vomiting Â±e 20%â€&quot;35% 20% About 13% 25% Â± â€&quot; Â±" exact="Diarrhea" post="Â± ï¼‹ ï¼‹ About 13% 25% Â± Â± Â±"/>
 <result pre="About 13% 25% Â± Â± Â± Later stage of onset" exact="Bilateral" post="pneumonia ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ Â± NA"/>
 <result pre="13% 25% Â± Â± Â± Later stage of onset Bilateral" exact="pneumonia" post="ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ Â± NA Ground"/>
 <result pre="ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ Â± NA Ground glass" exact="pneumonia" post="ï¼‹ ï¼‹ ï¼‹ ï¼‹ Â± â€&quot; â€&quot; NA Hepatic"/>
 <result pre="glass pneumonia ï¼‹ ï¼‹ ï¼‹ ï¼‹ Â± â€&quot; â€&quot; NA" exact="Hepatic" post="injury Â± ï¼‹ ï¼‹ ï¼‹ Â± ï¼‹ â€&quot; NA"/>
 <result pre="Hepatic injury Â± ï¼‹ ï¼‹ ï¼‹ Â± ï¼‹ â€&quot; NA" exact="Kidney" post="injury ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ â€&quot; ï¼‹"/>
 <result pre="Kidney injury ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ â€&quot; ï¼‹" exact="Heart" post="failure ï¼‹ â€&quot; â€&quot; Â± Â± ï¼‹ â€&quot; NA"/>
 <result pre="LDH increaseb ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ â€&quot; NA" exact="Lymphocytopenia" post="ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ â€&quot; ï¼‹ Critical"/>
 <result pre="[76], [77]] [[78], [79], [80]] [[81], [82], [83], [84]] aARDS," exact="Acute respiratory distress syndrome." post="bLDH, Lactate dehydrogenase. câ€œâ€&quot;â€�, uncommon or none. dâ€œï¼‹â€�, common."/>
 <result pre="[77]] [[78], [79], [80]] [[81], [82], [83], [84]] aARDS, Acute" exact="respiratory" post="distress syndrome. bLDH, Lactate dehydrogenase. câ€œâ€&quot;â€�, uncommon or none."/>
 <result pre="some cases. fNA, data unavailable. At the late stage of" exact="disease" post="onset, compared with the seasonal viruses, all of the"/>
 <result pre="HPHTs can result in similar severe clinical symptoms, such as" exact="bilateral" post="pneumonia, kidney damage, acute respiratory distress syndrome (ARDS), lactate"/>
 <result pre="result in similar severe clinical symptoms, such as bilateral pneumonia," exact="kidney damage," post="acute respiratory distress syndrome (ARDS), lactate dehydrogenase, and lymphocytopenia."/>
 <result pre="similar severe clinical symptoms, such as bilateral pneumonia, kidney damage," exact="acute" post="respiratory distress syndrome (ARDS), lactate dehydrogenase, and lymphocytopenia. In"/>
 <result pre="severe clinical symptoms, such as bilateral pneumonia, kidney damage, acute" exact="respiratory" post="distress syndrome (ARDS), lactate dehydrogenase, and lymphocytopenia. In addition,"/>
 <result pre="symptoms, such as bilateral pneumonia, kidney damage, acute respiratory distress" exact="syndrome" post="(ARDS), lactate dehydrogenase, and lymphocytopenia. In addition, three HPCoVs"/>
 <result pre="dehydrogenase, and lymphocytopenia. In addition, three HPCoVs and H7N9 IAV" exact="infection" post="usually showed ground glass pneumonia. MERS-CoV, SARS-CoV, H7N9 IAV,"/>
 <result pre="more hepatic injury. SARS-CoV-2 and H5N1 IAV meanwhile caused more" exact="heart" post="failure. The critical patient ratio of the HPHTs infection"/>
 <result pre="more heart failure. The critical patient ratio of the HPHTs" exact="infection" post="can be 10%â€&quot;70% after 2â€&quot;10 days of the disease"/>
 <result pre="HPHTs infection can be 10%â€&quot;70% after 2â€&quot;10 days of the" exact="disease" post="development. To detect the causative viruses, similar measures were"/>
 <result pre="specimen can be swabs, blood, or trachea extracts. Then the" exact="viral" post="RNAs can be directly identified by reverse transcription polymerase"/>
 <result pre="pathological data that were collected from autopsy, lung biopsies and" exact="chest" post="computed tomography (CT) scan are summarized in TableÂ 3"/>
 <result pre="manifestations of the lung pathological change were inflammatory exudation or" exact="acute" post="diffuse alveolar damage (DAD), with hyaline membrane formation, fibrin"/>
 <result pre="of the lung pathological change were inflammatory exudation or acute" exact="diffuse" post="alveolar damage (DAD), with hyaline membrane formation, fibrin mucoid"/>
 <result pre="mucoid exudation, interstitial and alveolar edema, inflammatory interstitial infiltration and" exact="vascular" post="congestion, epithelial cell proliferation, and pulmonary consolidation. However, there"/>
 <result pre="interstitial and alveolar edema, inflammatory interstitial infiltration and vascular congestion," exact="epithelial" post="cell proliferation, and pulmonary consolidation. However, there is no"/>
 <result pre="inflammatory interstitial infiltration and vascular congestion, epithelial cell proliferation, and" exact="pulmonary" post="consolidation. However, there is no fibrin exudate found in"/>
 <result pre="which may be related to the different stage of the" exact="disease" post="progression. Almost all of the virus infections caused bronchioles"/>
 <result pre="stage of the disease progression. Almost all of the virus" exact="infections" post="caused bronchioles injury except COVID-19 and H7N9 IAV [85,86],"/>
 <result pre="was reported that HCoVs were found to be associated with" exact="bronchiolitis" post="in immunocompromised people, the elderly and young children, but"/>
 <result pre="immunocompromised people, the elderly and young children, but showed light" exact="disease" post="in the lungs. TableÂ 3 The pathological changes of"/>
 <result pre="MERS-CoV SARS-CoV H7N9 IAV H1N1pdm09 H5N1 IAV HCoVs H3N2 IAV" exact="Diffuse" post="alveolar damage ï¼‹a ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ â€&quot;b"/>
 <result pre="membrane ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ â€&quot; ï¼‹ The" exact="pulmonary" post="interstitial edema and lymphocytic infiltration ï¼‹ ï¼‹ ï¼‹ ï¼‹"/>
 <result pre="Fibromyxoid exudation ï¼‹ â€&quot; ï¼‹ ï¼‹ ï¼‹ ï¼‹ â€&quot; ï¼‹" exact="Pulmonary" post="consolidation ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ ï¼‹ â€&quot; NA"/>
 <result pre="lopinavir/ritonavir. Ribavirin is similar to guanosine and inosine and interfere" exact="viral" post="RNA replication, which is more frequently used in combination"/>
 <result pre="is more frequently used in combination with interferons to treat" exact="chronic hepatitis C" post="infection [108]. Lopinavir and ritonavir are two protease inhibitors"/>
 <result pre="more frequently used in combination with interferons to treat chronic" exact="hepatitis C" post="infection [108]. Lopinavir and ritonavir are two protease inhibitors"/>
 <result pre="used in combination with interferons to treat chronic hepatitis C" exact="infection" post="[108]. Lopinavir and ritonavir are two protease inhibitors previously"/>
 <result pre="analog that mimics adenosine for previously treatment of the Ebola" exact="virus infection" post="[110]. Health authorities in China have initiated clinical trials"/>
 <result pre="that mimics adenosine for previously treatment of the Ebola virus" exact="infection" post="[110]. Health authorities in China have initiated clinical trials"/>
 <result pre="Science started phase III trial. National Institute of Allergy and" exact="Infectious" post="Diseases (NIAID) in the US are conducting phase II"/>
 <result pre="started phase III trial. National Institute of Allergy and Infectious" exact="Diseases" post="(NIAID) in the US are conducting phase II trial."/>
 <result pre="hydroxychloroquine. It was reported that these two drugs may inhibit" exact="viral" post="entry by affecting PH dependent endocytosis, and they may"/>
 <result pre="by affecting PH dependent endocytosis, and they may also affect" exact="viral" post="glycosylation by inhibiting glycosyl-transferases [113]. They were approved to"/>
 <result pre="were approved to treat or prevent malaria, as well as" exact="rheumatoid arthritis," post="or systemic lupus erythematosus etc. Moreover, hydroxychloroquine showed fewer"/>
 <result pre="treat or prevent malaria, as well as rheumatoid arthritis, or" exact="systemic" post="lupus erythematosus etc. Moreover, hydroxychloroquine showed fewer side effects"/>
 <result pre="or prevent malaria, as well as rheumatoid arthritis, or systemic" exact="lupus erythematosus" post="etc. Moreover, hydroxychloroquine showed fewer side effects than chloroquine"/>
 <result pre="they have a relatively large side effect on the human" exact="central nervous system," post="thus are no longer recommended by WHO as the"/>
 <result pre="marboxil, with a brand name of Xofloza, can target to" exact="viral" post="polymerase acidic protein (PA), block its endonuclease function, leading"/>
 <result pre="inhibition of virus mRNA transcription and effectively prevent influenza A" exact="virus infection" post="[[125], [126], [127]]. The antiviral spectrum of Xofloza includes"/>
 <result pre="of virus mRNA transcription and effectively prevent influenza A virus" exact="infection" post="[[125], [126], [127]]. The antiviral spectrum of Xofloza includes"/>
 <result pre="strains and influenza strains resistant to oseltamivir, significantly reducing the" exact="viral" post="load compared with oseltamivir [128]. T-705 is a new"/>
 <result pre="a wide range of viruses by directly entering into the" exact="viral" post="RNA chain or by binding directly to the viral"/>
 <result pre="the viral RNA chain or by binding directly to the" exact="viral" post="RNA polymerase domain to block viral RNA chain replication"/>
 <result pre="binding directly to the viral RNA polymerase domain to block" exact="viral" post="RNA chain replication and transcription [129,130]. It has been"/>
 <result pre="currently in clinical development stage or partly approved for influenza" exact="virus infection" post="[[138], [139], [140]]. Considering the antigen drift and shift"/>
 <result pre="in clinical development stage or partly approved for influenza virus" exact="infection" post="[[138], [139], [140]]. Considering the antigen drift and shift"/>
 <result pre="which may be useful for the treatment of severe influenza" exact="disease" post="[144]. 6 Prevention There are many types of vaccines"/>
 <result pre="that have been used or are under investigation for human" exact="viral" post="disease, such as live attenuated virus vaccine, inactivated whole"/>
 <result pre="protein has the ability to induce neutralizing antibodies to stop" exact="virus infection" post="[145,146], which shines light on SARS-CoV-2 vaccine study. For"/>
 <result pre="has the ability to induce neutralizing antibodies to stop virus" exact="infection" post="[145,146], which shines light on SARS-CoV-2 vaccine study. For"/>
 <result pre="Their phase I trial was finished on March 27. In" exact="total" post="108 volunteers have completed the centralized medical observation without"/>
 <result pre="S protein, a major direct receptor interaction protein, and other" exact="viral" post="proteins may continue modifying themselves to better adapt to"/>
 <result pre="many characteristics, especially in HPHTs. Most of them infect the" exact="respiratory" post="tract through direct contact and airway droplets and cause"/>
 <result pre="humans. SARS-CoV, H1N1pdm09, and H5N1 viruses easily infect younger people." exact="Severe" post="patients usually infected with HPHTs develop bilateral pneumonia, ARDS,"/>
 <result pre="infect younger people. Severe patients usually infected with HPHTs develop" exact="bilateral" post="pneumonia, ARDS, respiratory failure, and even death. CT and"/>
 <result pre="Severe patients usually infected with HPHTs develop bilateral pneumonia, ARDS," exact="respiratory" post="failure, and even death. CT and autopsy showed that"/>
 <result pre="and even death. CT and autopsy showed that the main" exact="pulmonary" post="pathological manifestations were DAD, hyaline membrane formation, alveolar and"/>
 <result pre="1PanX.OjciusD.M.GaoT.LiZ.PanC.PanC.Lessons learned from the 2019-nCoV epidemic on prevention of future" exact="infectious" post="diseasesMicrobes Infect222020869132088333 2https://www.who.int/emergencies/diseases/novel-coronavirus-2019 3MahaseE.Covid-19: outbreak could last until spring"/>
 <result pre="see 7.9 million hospitalised in the UKBMJ3682020m107132179567 4KhodamoradiZ.MoghadamiM.LotfiM.Co-infection of coronavirus" exact="disease" post="2019 and influenza A: a report from IranArch Iran"/>
 <result pre="patient with pneumonia, ChinaEmerg Infect Dis262020 6DingQ.LuP.FanY.XiaY.LiuM.The clinical characteristics of" exact="pneumonia" post="patients coinfected with 2019 novel coronavirus and influenza virus"/>
 <result pre="coronavirusesTrends Immunol41202035535932249063 9HeY.ZhuQ.LiuS.ZhouY.YangB.LiJ.Identification of a critical neutralization determinant of severe" exact="acute" post="respiratory syndrome (SARS)-associated coronavirus: importance for designing SARS vaccinesVirology3342005748215749124"/>
 <result pre="Immunol41202035535932249063 9HeY.ZhuQ.LiuS.ZhouY.YangB.LiJ.Identification of a critical neutralization determinant of severe acute" exact="respiratory" post="syndrome (SARS)-associated coronavirus: importance for designing SARS vaccinesVirology3342005748215749124 10XiaS.LiuM.WangC.XuW.LanQ.FengS.Inhibition"/>
 <result pre="9HeY.ZhuQ.LiuS.ZhouY.YangB.LiJ.Identification of a critical neutralization determinant of severe acute respiratory" exact="syndrome" post="(SARS)-associated coronavirus: importance for designing SARS vaccinesVirology3342005748215749124 10XiaS.LiuM.WangC.XuW.LanQ.FengS.Inhibition of"/>
 <result pre="importance for designing SARS vaccinesVirology3342005748215749124 10XiaS.LiuM.WangC.XuW.LanQ.FengS.Inhibition of SARS-CoV-2 (previously 2019-nCoV)" exact="infection" post="by a highly potent pan-coronavirus fusion inhibitor targeting its"/>
 <result pre="origin of human coronavirusesVirol J12201522126689940 13YuF.DuL.OjciusD.M.PanC.JiangS.Measures for diagnosing and treating" exact="infections" post="by a novel coronavirus responsible for a pneumonia outbreak"/>
 <result pre="and treating infections by a novel coronavirus responsible for a" exact="pneumonia" post="outbreak originating in Wuhan, ChinaMicrob Infect2220207479 14YinY.WunderinkR.G.MERS, SARS and"/>
 <result pre="against H1N1 influenza virus cross-react with alpha-cells of pancreatic isletsJÂ" exact="Diabetes" post="Investig92018265269 23WangJ.LiP.YuY.FuY.JiangH.LuM.Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunityScience3672020 24PanC.CheungB.TanS.LiC.LiL.LiuS.Genomic"/>
 <result pre="hemagglutinin to switch its receptor specificityCell15320131475148523746829 27SamjiT.Influenza A: understanding the" exact="viral" post="life cycleYale J Biol Med82200915315920027280 28GauntE.R.HardieA.ClaasE.C.SimmondsP.TempletonK.E.Epidemiology and clinical presentations"/>
 <result pre="cross-species transmissionBiochem Biophys Res Commun385200940240719463787 30AllenJ.D.RossT.M.H3N2 influenza viruses in humans:" exact="viral" post="mechanisms, evolution, and evaluationHum Vaccines Immunother14201818401847 31LiuY.NingZ.ChenY.GuoM.LiuY.GaliN.K.Aerodynamic analysis of"/>
 <result pre="two Wuhan hospitalsNature202010.1038/s41586-020-2271-3[online ahead of print] 32BaharoonS.MemishZ.A.MERS-CoV as an emerging" exact="respiratory" post="illness: a review of prevention methodsTrav Med Infect Dis2019101520"/>
 <result pre="evidence to detect antigenic driftVaccine29Suppl 22011B42B4821757103 39WuX.XiaoL.LiL.Research progress on human" exact="infection" post="with avian influenza H7N9Front Med14202082031989396 40SunY.CaoY.LiZ.BaiT.ZhangH.HuS.X.Cross-neutralizing anti-hemagglutinin antibodies isolated"/>
 <result pre="detect antigenic driftVaccine29Suppl 22011B42B4821757103 39WuX.XiaoL.LiL.Research progress on human infection with" exact="avian influenza" post="H7N9Front Med14202082031989396 40SunY.CaoY.LiZ.BaiT.ZhangH.HuS.X.Cross-neutralizing anti-hemagglutinin antibodies isolated from patients infected"/>
 <result pre="H7N9Front Med14202082031989396 40SunY.CaoY.LiZ.BaiT.ZhangH.HuS.X.Cross-neutralizing anti-hemagglutinin antibodies isolated from patients infected with" exact="avian influenza" post="A (H5N1) virusBiomed Environ Sci33202010311332131957 41ImaiM.HerfstS.SorrellE.M.SchrauwenE.J.LinsterM.De GraafM.Transmission of influenza"/>
 <result pre="influenza A/H5N1 viruses in mammalsVirus Res1782013152023954580 42TannerW.D.TothD.J.GundlapalliA.V.The pandemic potential of" exact="avian influenza" post="A(H7N9) virus: a reviewEpidemiol Infect14320153359337426205078 43AlgahtaniH.SubahiA.ShirahB.Neurological complications of Middle"/>
 <result pre="A(H7N9) virus: a reviewEpidemiol Infect14320153359337426205078 43AlgahtaniH.SubahiA.ShirahB.Neurological complications of Middle East" exact="respiratory" post="syndrome coronavirus: a report of two cases and review"/>
 <result pre="virus: a reviewEpidemiol Infect14320153359337426205078 43AlgahtaniH.SubahiA.ShirahB.Neurological complications of Middle East respiratory" exact="syndrome" post="coronavirus: a report of two cases and review of"/>
 <result pre="structure of the 2019-nCoV spike in the prefusion conformationScience36720201260126332075877 46SkowronskiD.M.AstellC.BrunhamR.C.LowD.E.PetricM.RoperR.L.Severe" exact="acute" post="respiratory syndrome (SARS): a year in reviewAnnu Rev Med56200535738115660517"/>
 <result pre="of the 2019-nCoV spike in the prefusion conformationScience36720201260126332075877 46SkowronskiD.M.AstellC.BrunhamR.C.LowD.E.PetricM.RoperR.L.Severe acute" exact="respiratory" post="syndrome (SARS): a year in reviewAnnu Rev Med56200535738115660517 47ThompsonC.I.BarclayW.S.ZambonM.C.PicklesR.J.Infection"/>
 <result pre="the 2019-nCoV spike in the prefusion conformationScience36720201260126332075877 46SkowronskiD.M.AstellC.BrunhamR.C.LowD.E.PetricM.RoperR.L.Severe acute respiratory" exact="syndrome" post="(SARS): a year in reviewAnnu Rev Med56200535738115660517 47ThompsonC.I.BarclayW.S.ZambonM.C.PicklesR.J.Infection of"/>
 <result pre="and clinical characteristics of 99 cases of 2019 novel coronavirus" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet395202050751332007143 59SengaM.ArabiY.M.FowlerR.A.Clinical spectrum of"/>
 <result pre="China: a descriptive studyLancet395202050751332007143 59SengaM.ArabiY.M.FowlerR.A.Clinical spectrum of the Middle East" exact="respiratory" post="syndrome coronavirus (MERS-CoV)JÂ Infect Public Health10201719119427140697 60MemishZ.A.PerlmanS.Van KerkhoveM.D.ZumlaA.Middle East"/>
 <result pre="a descriptive studyLancet395202050751332007143 59SengaM.ArabiY.M.FowlerR.A.Clinical spectrum of the Middle East respiratory" exact="syndrome" post="coronavirus (MERS-CoV)JÂ Infect Public Health10201719119427140697 60MemishZ.A.PerlmanS.Van KerkhoveM.D.ZumlaA.Middle East respiratory"/>
 <result pre="respiratory syndrome coronavirus (MERS-CoV)JÂ Infect Public Health10201719119427140697 60MemishZ.A.PerlmanS.Van KerkhoveM.D.ZumlaA.Middle East" exact="respiratory" post="syndromeLancet39520201063107732145185 61AssiriA.Al-TawfiqJ.A.Al-RabeeahA.A.Al-RabiahF.A.Al-HajjarS.Al-BarrakA.Epidemiological, demographic, and clinical characteristics of 47 cases"/>
 <result pre="demographic, and clinical characteristics of 47 cases of Middle East" exact="respiratory" post="syndrome coronavirus disease from Saudi Arabia: a descriptive studyLancet"/>
 <result pre="and clinical characteristics of 47 cases of Middle East respiratory" exact="syndrome" post="coronavirus disease from Saudi Arabia: a descriptive studyLancet Infect"/>
 <result pre="characteristics of 47 cases of Middle East respiratory syndrome coronavirus" exact="disease" post="from Saudi Arabia: a descriptive studyLancet Infect Dis13201375276123891402 62HuiD.S.C.ZumlaA.Severe"/>
 <result pre="disease from Saudi Arabia: a descriptive studyLancet Infect Dis13201375276123891402 62HuiD.S.C.ZumlaA.Severe" exact="acute" post="respiratory syndrome: historical, epidemiologic, and clinical featuresInfect Dis Clin332019869889"/>
 <result pre="from Saudi Arabia: a descriptive studyLancet Infect Dis13201375276123891402 62HuiD.S.C.ZumlaA.Severe acute" exact="respiratory" post="syndrome: historical, epidemiologic, and clinical featuresInfect Dis Clin332019869889 63LeungG.M.HedleyA.J.HoL.M.ChauP.WongI.O.ThachT.Q.The"/>
 <result pre="epidemiologic, and clinical featuresInfect Dis Clin332019869889 63LeungG.M.HedleyA.J.HoL.M.ChauP.WongI.O.ThachT.Q.The epidemiology of severe" exact="acute" post="respiratory syndrome in the 2003 Hong Kong epidemic: an"/>
 <result pre="and clinical featuresInfect Dis Clin332019869889 63LeungG.M.HedleyA.J.HoL.M.ChauP.WongI.O.ThachT.Q.The epidemiology of severe acute" exact="respiratory" post="syndrome in the 2003 Hong Kong epidemic: an analysis"/>
 <result pre="clinical featuresInfect Dis Clin332019869889 63LeungG.M.HedleyA.J.HoL.M.ChauP.WongI.O.ThachT.Q.The epidemiology of severe acute respiratory" exact="syndrome" post="in the 2003 Hong Kong epidemic: an analysis of"/>
 <result pre="the greater Toronto areaJÂ Am Med Assoc289200328012809 65PeirisJ.S.ChuC.M.ChengV.C.ChanK.S.HungI.F.PoonL.L.Clinical progression and" exact="viral" post="load in a community outbreak of coronavirus-associated SARS pneumonia:"/>
 <result pre="prospective studyLancet36120031767177212781535 66YuL.WangZ.ChenY.DingW.JiaH.ChanJ.F.Clinical, virological, and histopathological manifestations of fatal human" exact="infections" post="by avian influenza A(H7N9) virusClin Infect Dis5720131449145723943822 67YuH.CowlingB.J.FengL.LauE.H.LiaoQ.TsangT.K.Human infection"/>
 <result pre="66YuL.WangZ.ChenY.DingW.JiaH.ChanJ.F.Clinical, virological, and histopathological manifestations of fatal human infections by" exact="avian influenza" post="A(H7N9) virusClin Infect Dis5720131449145723943822 67YuH.CowlingB.J.FengL.LauE.H.LiaoQ.TsangT.K.Human infection with avian influenza"/>
 <result pre="human infections by avian influenza A(H7N9) virusClin Infect Dis5720131449145723943822 67YuH.CowlingB.J.FengL.LauE.H.LiaoQ.TsangT.K.Human" exact="infection" post="with avian influenza A H7N9 virus: an assessment of"/>
 <result pre="by avian influenza A(H7N9) virusClin Infect Dis5720131449145723943822 67YuH.CowlingB.J.FengL.LauE.H.LiaoQ.TsangT.K.Human infection with" exact="avian influenza" post="A H7N9 virus: an assessment of clinical severityLancet382201313814523803487 68GaoH.N.LuH.Z.CaoB.DuB.ShangH.GanJ.H.Clinical"/>
 <result pre="studyPloS One82013e73362 70PoepplW.HellM.HerknerH.StoiserB.FritscheG.Schurz-BamiehN.Clinical aspects of 2009 pandemic influenza A (H1N1)" exact="virus infection" post="in AustriaInfection39201134135221544585 71PatelM.DennisA.FlutterC.KhanZ.Pandemic (H1N1) 2009 influenzaBr J Anaesth104201012814220053625 72KhandakerG.DierigA.RashidH.KingC.HeronL.BooyR.Systematic"/>
 <result pre="One82013e73362 70PoepplW.HellM.HerknerH.StoiserB.FritscheG.Schurz-BamiehN.Clinical aspects of 2009 pandemic influenza A (H1N1) virus" exact="infection" post="in AustriaInfection39201134135221544585 71PatelM.DennisA.FlutterC.KhanZ.Pandemic (H1N1) 2009 influenzaBr J Anaesth104201012814220053625 72KhandakerG.DierigA.RashidH.KingC.HeronL.BooyR.Systematic"/>
 <result pre="humansJÂ Clin Virol45200916917319540800 75LiemN.T.TungC.V.HienN.D.HienT.T.ChauN.Q.LongH.T.Clinical features of human influenza A (H5N1)" exact="infection" post="in Vietnam: 2004-2006Clin Infect Dis4820091639164619435433 76HuiD.S.Review of clinical symptoms"/>
 <result pre="12008S10S1318366521 77YuH.GaoZ.FengZ.ShuY.XiangN.ZhouL.Clinical characteristics of 26 human cases of highly pathogenic" exact="avian influenza" post="A (H5N1) virus infection in ChinaPloS One32008e298518716658 78ZhangS.F.TuoJ.L.HuangX.B.ZhuX.ZhangD.M.ZhouK.Epidemiology characteristics"/>
 <result pre="26 human cases of highly pathogenic avian influenza A (H5N1)" exact="virus infection" post="in ChinaPloS One32008e298518716658 78ZhangS.F.TuoJ.L.HuangX.B.ZhuX.ZhangD.M.ZhouK.Epidemiology characteristics of human coronaviruses in"/>
 <result pre="human cases of highly pathogenic avian influenza A (H5N1) virus" exact="infection" post="in ChinaPloS One32008e298518716658 78ZhangS.F.TuoJ.L.HuangX.B.ZhuX.ZhangD.M.ZhouK.Epidemiology characteristics of human coronaviruses in"/>
 <result pre="ChinaPloS One32008e298518716658 78ZhangS.F.TuoJ.L.HuangX.B.ZhuX.ZhangD.M.ZhouK.Epidemiology characteristics of human coronaviruses in patients with" exact="respiratory" post="infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015"/>
 <result pre="One32008e298518716658 78ZhangS.F.TuoJ.L.HuangX.B.ZhuX.ZhangD.M.ZhouK.Epidemiology characteristics of human coronaviruses in patients with respiratory" exact="infection" post="symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in"/>
 <result pre="in GuangzhouPloS One132018e0191789 79CabecaT.K.GranatoC.BelleiN.Epidemiological and clinical features of human coronavirus" exact="infections" post="among different subsets of patientsInfluenza Other Respir Viruses720131040104723462106 80PyrcK.BerkhoutB.van"/>
 <result pre="Virol8120073051305717079323 81WieS.H.SoB.H.SongJ.Y.CheongH.J.SeoY.B.ChoiS.H.AÂ comparison of the clinical and epidemiological characteristics of" exact="adult" post="patients with laboratory-confirmed influenza A or B during the"/>
 <result pre="seasons: 2004-2005 through 2007-2008Influenza Other Respir Viruses62012374321668663 83RogoL.D.RezaeiF.MarashiS.M.YekaninejadM.S.NaseriM.GhavamiN.Seasonal influenza A/H3N2" exact="virus infection" post="and IL-1Beta, IL-10, IL-17, and IL-28 polymorphisms in Iranian"/>
 <result pre="2004-2005 through 2007-2008Influenza Other Respir Viruses62012374321668663 83RogoL.D.RezaeiF.MarashiS.M.YekaninejadM.S.NaseriM.GhavamiN.Seasonal influenza A/H3N2 virus" exact="infection" post="and IL-1Beta, IL-10, IL-17, and IL-28 polymorphisms in Iranian"/>
 <result pre="features between influenza A H1N1, A H3N2, and B in" exact="adult" post="patientsRespirology8200323123312753540 85ZhangZ.XiaY.LuY.YangJ.ZhangL.SuH.Prediction of H7N9 epidemic in ChinaChin Med J127201425426024438612"/>
 <result pre="Med J127201425426024438612 86ZhangS.GuD.OuyangX.XieW.Proinflammatory effects of the hemagglutinin protein of the" exact="avian influenza" post="A (H7N9) virus and microRNAmediated homeostasis response in THP1"/>
 <result pre="THP1 cellsMol Med Rep1220156241624626238163 87XuZ.ShiL.WangY.ZhangJ.HuangL.ZhangC.Pathological findings of COVID-19 associated with" exact="acute" post="respiratory distress syndromeLancet Respir Med8202042042232085846 88ShiH.HanX.JiangN.CaoY.AlwalidO.GuJ.Radiological findings from 81"/>
 <result pre="cellsMol Med Rep1220156241624626238163 87XuZ.ShiL.WangY.ZhangJ.HuangL.ZhangC.Pathological findings of COVID-19 associated with acute" exact="respiratory" post="distress syndromeLancet Respir Med8202042042232085846 88ShiH.HanX.JiangN.CaoY.AlwalidO.GuJ.Radiological findings from 81 patients"/>
 <result pre="syndromeLancet Respir Med8202042042232085846 88ShiH.HanX.JiangN.CaoY.AlwalidO.GuJ.Radiological findings from 81 patients with COVID-19" exact="pneumonia" post="in Wuhan, China: a descriptive studyLancet Infect Dis20202042543432105637 89BartonL.M.DuvalE.J.StrobergE.GhoshS.MukhopadhyayS.COVID-19"/>
 <result pre="and ultrastructural findings of a fatal case of Middle East" exact="respiratory" post="syndrome coronavirus infection in the United Arab Emirates, April"/>
 <result pre="ultrastructural findings of a fatal case of Middle East respiratory" exact="syndrome" post="coronavirus infection in the United Arab Emirates, April 2014Am"/>
 <result pre="of a fatal case of Middle East respiratory syndrome coronavirus" exact="infection" post="in the United Arab Emirates, April 2014Am J Pathol186201665265826857507"/>
 <result pre="Emirates, April 2014Am J Pathol186201665265826857507 91NichollsJ.M.PoonL.L.LeeK.C.NgW.F.LaiS.T.LeungC.Y.Lung pathology of fatal severe" exact="acute" post="respiratory syndromeLancet36120031773177812781536 92FranksT.J.ChongP.Y.ChuiP.GalvinJ.R.LourensR.M.ReidA.H.Lung pathology of severe acute respiratory syndrome"/>
 <result pre="April 2014Am J Pathol186201665265826857507 91NichollsJ.M.PoonL.L.LeeK.C.NgW.F.LaiS.T.LeungC.Y.Lung pathology of fatal severe acute" exact="respiratory" post="syndromeLancet36120031773177812781536 92FranksT.J.ChongP.Y.ChuiP.GalvinJ.R.LourensR.M.ReidA.H.Lung pathology of severe acute respiratory syndrome (SARS):"/>
 <result pre="of fatal severe acute respiratory syndromeLancet36120031773177812781536 92FranksT.J.ChongP.Y.ChuiP.GalvinJ.R.LourensR.M.ReidA.H.Lung pathology of severe" exact="acute" post="respiratory syndrome (SARS): a study of 8 autopsy cases"/>
 <result pre="fatal severe acute respiratory syndromeLancet36120031773177812781536 92FranksT.J.ChongP.Y.ChuiP.GalvinJ.R.LourensR.M.ReidA.H.Lung pathology of severe acute" exact="respiratory" post="syndrome (SARS): a study of 8 autopsy cases from"/>
 <result pre="severe acute respiratory syndromeLancet36120031773177812781536 92FranksT.J.ChongP.Y.ChuiP.GalvinJ.R.LourensR.M.ReidA.H.Lung pathology of severe acute respiratory" exact="syndrome" post="(SARS): a study of 8 autopsy cases from SingaporeHum"/>
 <result pre="study of 8 autopsy cases from SingaporeHum Pathol34200374374814506633 93GuJ.GongE.ZhangB.ZhengJ.GaoZ.ZhongY.Multiple organ" exact="infection" post="and the pathogenesis of SARSJÂ Exp Med202200541542416043521 94FengY.HuL.LuS.ChenQ.ZhengY.ZengD.Molecular pathology"/>
 <result pre="SARSJÂ Exp Med202200541542416043521 94FengY.HuL.LuS.ChenQ.ZhengY.ZengD.Molecular pathology analyses of two fatal human" exact="infections" post="of avian influenza A(H7N9) virusJÂ Clin Pathol682015576325378539 95WangQ.ZhangZ.ShiY.JiangY.Emerging H7N9"/>
 <result pre="Med202200541542416043521 94FengY.HuL.LuS.ChenQ.ZhengY.ZengD.Molecular pathology analyses of two fatal human infections of" exact="avian influenza" post="A(H7N9) virusJÂ Clin Pathol682015576325378539 95WangQ.ZhangZ.ShiY.JiangY.Emerging H7N9 influenza A (novel"/>
 <result pre="and virology findings in cases of fatal influenza A H1N1" exact="virus infection" post="in 2009-2010Histopathology60201232633522211291 97MauadT.HajjarL.A.CallegariG.D.da SilvaL.F.SchoutD.GalasF.R.Lung pathology in fatal novel human"/>
 <result pre="virology findings in cases of fatal influenza A H1N1 virus" exact="infection" post="in 2009-2010Histopathology60201232633522211291 97MauadT.HajjarL.A.CallegariG.D.da SilvaL.F.SchoutD.GalasF.R.Lung pathology in fatal novel human"/>
 <result pre="(H1N1) infectionAm J Respir Crit Care Med1812010727919875682 98BaiL.GuL.CaoB.ZhaiX.L.LuM.LuY.Clinical features of" exact="pneumonia" post="caused by 2009 influenza A(H1N1) virus in Beijing, ChinaChest13920111156116420864615"/>
 <result pre="influenza in VietnamMod Pathol26201335736923174938 100KortewegC.GuJ.Pathology, molecular biology, and pathogenesis of" exact="avian influenza" post="A (H5N1) infection in humansAm J Pathol17220081155117018403604 101UiprasertkulM.KitphatiR.PuthavathanaP.KriwongR.KongchanagulA.UngchusakK.Apoptosis and"/>
 <result pre="100KortewegC.GuJ.Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1)" exact="infection" post="in humansAm J Pathol17220081155117018403604 101UiprasertkulM.KitphatiR.PuthavathanaP.KriwongR.KongchanagulA.UngchusakK.Apoptosis and pathogenesis of avian"/>
 <result pre="(H5N1) infection in humansAm J Pathol17220081155117018403604 101UiprasertkulM.KitphatiR.PuthavathanaP.KriwongR.KongchanagulA.UngchusakK.Apoptosis and pathogenesis of" exact="avian influenza" post="A (H5N1) virus in humansEmerg Infect Dis13200770871217553248 102PeirisJ.S.YuW.C.LeungC.W.CheungC.Y.NgW.F.NichollsJ.M.Re-emergence of"/>
 <result pre="HKU1-associated community-acquired pneumoniaJÂ Infect Dis19220051898190716267760 104VabretA.MourezT.GouarinS.PetitjeanJ.FreymuthF.An outbreak of coronavirus OC43" exact="respiratory" post="infection in Normandy, FranceClin Infect Dis36200398598912684910 105PeneF.MerlatA.VabretA.RozenbergF.BuzynA.DreyfusF.Coronavirus 229E-related pneumonia"/>
 <result pre="community-acquired pneumoniaJÂ Infect Dis19220051898190716267760 104VabretA.MourezT.GouarinS.PetitjeanJ.FreymuthF.An outbreak of coronavirus OC43 respiratory" exact="infection" post="in Normandy, FranceClin Infect Dis36200398598912684910 105PeneF.MerlatA.VabretA.RozenbergF.BuzynA.DreyfusF.Coronavirus 229E-related pneumonia in"/>
 <result pre="OC43 respiratory infection in Normandy, FranceClin Infect Dis36200398598912684910 105PeneF.MerlatA.VabretA.RozenbergF.BuzynA.DreyfusF.Coronavirus 229E-related" exact="pneumonia" post="in immunocompromised patientsClin Infect Dis37200392993213130404 106EbiharaT.EndoR.MaX.IshiguroN.KikutaH.Detection of human coronavirus"/>
 <result pre="Med Res40200965566120304252 108HallC.B.Ribavirin. Infect Dis Newsl (N Y)41985737532336861 109DyallJ.GrossR.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.HensleyL.E.Middle East" exact="respiratory" post="syndrome and severe acute respiratory syndrome: current therapeutic options"/>
 <result pre="Res40200965566120304252 108HallC.B.Ribavirin. Infect Dis Newsl (N Y)41985737532336861 109DyallJ.GrossR.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.HensleyL.E.Middle East respiratory" exact="syndrome" post="and severe acute respiratory syndrome: current therapeutic options and"/>
 <result pre="Dis Newsl (N Y)41985737532336861 109DyallJ.GrossR.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.HensleyL.E.Middle East respiratory syndrome and severe" exact="acute" post="respiratory syndrome: current therapeutic options and potential targets for"/>
 <result pre="Newsl (N Y)41985737532336861 109DyallJ.GrossR.KindrachukJ.JohnsonR.F.OlingerG.G.Jr.HensleyL.E.Middle East respiratory syndrome and severe acute" exact="respiratory" post="syndrome: current therapeutic options and potential targets for novel"/>
 <result pre="for coronavirus drug remdesivirNature202010.1038/d41586-020-01295-8[online ahead of print] 111CaoY.C.DengQ.X.DaiS.X.Remdesivir for severe" exact="acute" post="respiratory syndrome coronavirus 2 causing COVID-19: an evaluation of"/>
 <result pre="coronavirus drug remdesivirNature202010.1038/d41586-020-01295-8[online ahead of print] 111CaoY.C.DengQ.X.DaiS.X.Remdesivir for severe acute" exact="respiratory" post="syndrome coronavirus 2 causing COVID-19: an evaluation of the"/>
 <result pre="drug remdesivirNature202010.1038/d41586-020-01295-8[online ahead of print] 111CaoY.C.DengQ.X.DaiS.X.Remdesivir for severe acute respiratory" exact="syndrome" post="coronavirus 2 causing COVID-19: an evaluation of the evidenceTrav"/>
 <result pre="use of chloroquine and hydroxychloroquine in the management of coronavirus" exact="disease" post="2019 (COVID-19) pandemic: a timely reviewJÂ Toxicol Environ Health"/>
 <result pre="Chin Med202012632054304 117PizzornoA.PadeyB.TerrierO.Rosa-CalatravaM.Drug repurposing approaches for the treatment of influenza" exact="viral" post="infection: reviving old drugs to fight against a long-lived"/>
 <result pre="meta-analysesJÂ Antimicrob Chemother7220172990300728961794 122AbedY.PizzornoA.BouhyX.RheaumeC.BoivinG.Impact of potential permissive neuraminidase mutations on" exact="viral" post="fitness of the H275Y oseltamivir-resistant influenza A(H1N1)pdm09 virus inÂ"/>
 <result pre="a novel cap-dependent endonuclease (CEN) inhibitor for the treatment of" exact="acute" post="uncomplicated influenzaDrugs Today55201935936631250840 127KoszalkaP.TilmanisD.RoeM.VijaykrishnaD.HurtA.C.Baloxavir marboxil susceptibility of influenza viruses"/>
 <result pre="Asia-Pacific, 2012-2018Antivir Res1642019919630771405 128NgK.E.Xofluza (baloxavir marboxil) for the treatment of" exact="acute" post="uncomplicated influenzaPÂ T44201991130675086 129FurutaY.KomenoT.NakamuraT.Favipiravir (T-705), a broad spectrum inhibitor"/>
 <result pre="uncomplicated influenzaPÂ T44201991130675086 129FurutaY.KomenoT.NakamuraT.Favipiravir (T-705), a broad spectrum inhibitor of" exact="viral" post="RNA polymeraseProc Jpn Acad Ser B Phys Biol Sci932017449463"/>
 <result pre="virus inhibitorsJÂ Thorac Dis52013S149S15923977436 138SalvatoreM.SatlinM.J.JacobsS.E.JenkinsS.G.SchuetzA.N.MossR.B.DAS181 for treatment of parainfluenza virus" exact="infections" post="in hematopoietic stem cell transplant recipients at a single"/>
 <result pre="in hematopoietic stem cell transplant recipients at a single centerBiol" exact="Blood" post="Marrow Transplant22201696597026904972 139DhakalB.Dâ€™SouzaA.PasquiniM.SaberW.FenskeT.S.MossR.B.DAS181 treatment of severe parainfluenza virus 3"/>
 <result pre="Blood Marrow Transplant22201696597026904972 139DhakalB.Dâ€™SouzaA.PasquiniM.SaberW.FenskeT.S.MossR.B.DAS181 treatment of severe parainfluenza virus 3" exact="pneumonia" post="in allogeneic hematopoietic stem cell transplant recipients requiring mechanical"/>
 <result pre="1 randomized, double-blind, placebo-controlled, crossover trial of DAS181 (Fludase(R)) in" exact="adult" post="subjects with well-controlled asthmaBMC Infect Dis1620165426830468 141LvovD.K.BogdanovaV.S.KirillovI.M.ShchelkanovM.Y.BurtsevaE.I.BovinN.V.[Evolution of pandemic"/>
 <result pre="receptor-binding siteJÂ Mol Graph Model44201316116723831996 143Lâ€™VovD.K.BurtsevaE.I.PrilipovA.G.BogdanovaV.S.ShchelkanovM.BovinN.V.[A possible association of fatal" exact="pneumonia" post="with mutations of pandemic influenza A/H1N1 sw1 virus in"/>
</results>
